JPMorgan, Jefferies, Citi and Wells Fargo acted as joint book running managers for the offering.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BEAM:
- Beam Therapeutics announces ‘positive’ data from study of BEAM-302
- Beam Therapeutics price target raised to $25 from $24 at Scotiabank
- Cautious Optimism for Beam Therapeutics Amid Upcoming Milestones and Financial Considerations
- Beam Therapeutics: Promising Pipeline and Strong Financial Position Justify Buy Rating
- Biotech Alert: Searches spiking for these stocks today